ESLV yields 0.55% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, ESLV + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ESLV + JNJ for your $10,000?
ESLV aims for long-term capital appreciation by investing in large-cap US companies that exhibit value style characteristics. The actively managed fund uses a long-only investment approach and seeks to generate performance like its benchmark index of US companies with the highest value factor scores. The fund selects at least 75 companies using fundamental research that includes a values-based screening inspired by the Christian faith. Selection of undervalued securities is based on price-to-projected earnings while considering price-to-book, price-to-sales, price-to-cash flow, and dividend yield. The fund caps an industry or industry group by 25%, except when it represents 20% or more of the benchmark, allowing up to 35%. While actively managing the fund, the adviser monitors its holdings with full discretion to adjust the portfolio as necessary using research, quantitative modeling, and risk tools.
Full ESLV Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.